The FDA has approved Anzupgo (delgocitinib) cream for the topical treatment of moderate to severe chronic hand eczema in ...

Benefits of 7000 steps per day include lower risk for death and cardiovascular disease, diabetes, dementia, and depression.

RFK Jr may remove all 16 members of the advisory group that helps decide which preventive services are fully covered by insurance.

Tildrakizumab is an interleukin-23 antagonist approved under the brand name Ilumya for the treatment of plaque psoriasis.

With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of these therapies.

Nearly half of all Planned Parenthood patients use Medicaid to pay for services. Medicaid is the federal health care program for people with low incomes or disabilities. In her ruling, Talwani ...

The FDA is recommending that certain products containing 7-hydroxymitragynine be subject to the Controlled Substances Act.

A consensus-based definition for on-treatment remission for patients with plaque psoriasis has been published by the National Psoriasis Foundation.

The rate of opioid prescriptions from Mohs surgeons declined between 2014 and 2022, with specific factors associated with higher rates of prescribing.

There was a 1% increase in the number of births and a 1% decrease in the general fertility rate from 2023 to 2024.

Dupilumab use for atopic dermatitis and other conditions was associated with an increased risk of incident psoriasis but not psoriatic arthritis.

Patients perceived physicians as less competent, trustworthy, and empathetic if they used AI in their practice.